Ticker

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH - Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totaling 71,193 shares, a drop of 38.6% from the March 31st total of 115,865 shares. Based on an average daily trading volume, of 156,443 shares, the days-to-cover ratio is

Sigyn Therapeutics (OTCMKTS:SIGY - Get Free Report) and Shuttle Pharmaceuticals (NASDAQ: SHPH - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Risk and Volatility Sigyn Therapeutics has a

Gaithersburg, Maryland--(Newsfile Corp. - March 27, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its molecule.ai platform, significantly expanding its capabilities in therapeutic discovery and positioning the Company at the forefront of AI-driven drug development. The latest release introduces new models that enable users to…

Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its molecule.ai platform, significantly expanding its capabilities in therapeutic discovery and positioning the Company at the forefront of AI-driven drug development. The latest release introduces new models that enable users to…

Shuttle Pharmaceuticals (NASDAQ: SHPH - Get Free Report) and Tempest Therapeutics (NASDAQ: TPST - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk. Institutional and Insider Ownership 4.6% of Shuttle